阿里巴巴达摩院近日联手全球十余家顶级医疗机构，成功运用人工智能（AI）技术在胰腺癌早期筛查方面取得了突破性成果。在针对2万多真实世界连续病人群体的研究中，仅通过简单的平扫CT，便发现了31例临床漏诊的病变，其中包括2例早期胰腺癌病患。这一研究成果已登上国际顶级医疗期刊《自然·医学》（Nature Medicine），并被专门配发评论文章，预示着基于医疗影像AI的癌症筛查即将进入黄金时代。
英文翻译：
News content:
Alibaba’s DAMO Academy has recently achieved a breakthrough in the early screening of pancreatic cancer by collaborating with more than 10 of the world’s top medical institutions. Using artificial intelligence (AI) technology, the study successfully detected 31 cases of clinically missed lesions in over 20,000 continuous patient populations through simple CT scans. Among them, two early-stage pancreatic cancer patients were identified. This groundbreaking research has been published in the international top medical journal Nature Medicine, accompanied by a special commentary article. It predicts that cancer screening based on medical imaging AI is about to enter a golden age.
Title: Breaking the pancreatic cancer early screening dilemma with AI
Keywords: Pancreatic cancer, Early screening, Artificial intelligence
【来源】https://www.jiemian.com/article/10456958.html
Views: 2